Hospital de la Santa Creu, Tortosa Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2007
NCT00503516
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Hospital de la Santa Creu de Vic | Hospital de la Santa Creu (Tortosa)

Active Ingredients

Drugs in Phase 3 Trials (1)

megestrol (megace) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dementia (Phase 3)

Weight Loss (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1